Study: EPA and DHA Help Reduce Scarring After a Heart AttackPrint
The results of a post-heart attack clinical trial published recently in the American Heart Association’s journal Circulation are being called breakthrough. The randomized clinical trial done by researchers at Harvard Medical School and Brigham and Women’s Hospital showed that consuming 3360 milligrams of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) omega-3 fatty acids daily, paired with standard evidence-based medical care following a heart attack, reduces scarring in undamaged heart muscle and increases the heart’s ability to pump blood.
The researchers explain that heart failure remains common after a heart attack, despite advances in medical care. Omega-3s provide a significant benefit.
During the study, participants were started on the EPA and DHA regimen in the weeks immediately following a heart attack. Researchers speculate the study results may have been even better had participants started the omega-3 regimen within days of a heart attack instead. They also believe the success is directly related to the high dosage of EPA and DHA.
The study also found:
- A statistically significant reduction in biomarkers for cardiac inflammation
- Improved heart function directly related to omega-3 dosage
- No significant bleeding as a result of the high dose of omega-3s
The complete journal article can be found here.